Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 100
SponsorChildren's Hospital of Fudan University
About this trial
The researchers hope to establish an overall program of early genetic screening for neonatal critical illness in China, and to develop precise intervention strategies to assist clinical diagnosis and treatment of hereditary critical illness.
Eligibility criteria
Qualifiers
Postnatal age less than 100 days;
Perinatal death after 20 weeks of gestation (more than 500 g)
Can be retained biological samples for genetic screening;
Biological parent or guardian's informed consent.
Disqualifiers
Reluctance of parents to use genetic sequencing data for subsequent research;
Parents under 18 years of age or incapacitated for decision-making;
subjects older than 100 days;
Perinatal death less than 20 weeks of gestation or weight less than 500 g;
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
4,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Children's Hospital of Fudan University
Lead sponsor
International Peace Maternity and Child Health Hospital
Collaborator
Obstetrics & Gynecology Hospital of Fudan University
Collaborator
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborator
Shanghai Children's Medical Center
Collaborator
Shanghai Children's Hospital
Collaborator
Source ClinicalTrials.gov